Nataliya Kovalchuk, Clinical Professor at Stanford Radiation Oncology, shared a post by Applied Radiation Oncology on LinkedIn:
“Applied Radiation Oncology, thank you for the highlight!
This publication stirred up the conversation of using VMAT TBI on a newly developed multi-institutional trial for scleroderma patients! We were invited to write up the RT section of the trial and are excited to have it started!
Thank you for the opportunity to publish and share our experience!”
Quoting Applied Radiation Oncology‘s post:
“Using an Auto-Planned VMAT-TBI Technique for Myeloablative Autologous Hematopoietic Stem Cell Transplantation for Scleroderma (The STAT-2 Trial)
Read the full article.”
Other articles about Radiation Oncology on OncoDaily.